Licensing opportunities and technologies are sourced from our own drug discovery and diagnostics labs and the UK’s Medical Research Council.

LifeArc is responsible for the technology transfer of patented and protected technologies from the MRC, LifeArc and other academic and charitable organisations.

Therapeutics
MIF inhibitors for the treatment of inflammation
Inflammation

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
GalR2 Agonists for the Treatment of Pain
Neuropathic Pain

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
Beta amyloid-targeted therapeutic antibody
Alzheimer’s Disease

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
Anti-microbial agent with utility in tuberculosis
Anti-microbial

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
ALK ADC for the Treatment of Neuroblastoma
Cancer

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
IL16 antibodies for inflammation
Inflammation

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Devices & Software
Oxygen sensors for product packaging

Key Contact
Karen Law
Business Manager
+ 44 (0) 1438 544077
Therapeutics
Ang2 specific biotherapeutic
Biotherapeutic

Key Contact
Rachael Brooker
Business Manager
+ 44 (0)20 7391 7015
Therapeutics
MNK1/ MNK2 small molecule inhibitors for cancer
Cancer

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
Potent ULK1 inhibitors as novel cancer therapeutics
Cancer

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
Matriptase, a small molecule inhibitor
Inflammation

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
PAICS small molecule inhibitors for cancer
Cancer

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565